Anton Hagenbeek

26.9k total citations · 3 hit papers
263 papers, 16.4k citations indexed

About

Anton Hagenbeek is a scholar working on Pathology and Forensic Medicine, Hematology and Oncology. According to data from OpenAlex, Anton Hagenbeek has authored 263 papers receiving a total of 16.4k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Pathology and Forensic Medicine, 91 papers in Hematology and 73 papers in Oncology. Recurrent topics in Anton Hagenbeek's work include Lymphoma Diagnosis and Treatment (103 papers), Acute Myeloid Leukemia Research (62 papers) and Hematopoietic Stem Cell Transplantation (51 papers). Anton Hagenbeek is often cited by papers focused on Lymphoma Diagnosis and Treatment (103 papers), Acute Myeloid Leukemia Research (62 papers) and Hematopoietic Stem Cell Transplantation (51 papers). Anton Hagenbeek collaborates with scholars based in Netherlands, France and United States. Anton Hagenbeek's co-authors include Sandra J. Horning, Bertrand Coiffier, Richard I. Fisher, Richard T. Hoppe, Joseph M. Connors, Julie M. Vose, Anton C. Martens, Randy D. Gascoyne, Thierry Philip and Pieter Sonneveld and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Anton Hagenbeek

259 papers receiving 16.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Revised Response Criteria for Malignant Lymphoma

2007 3.2k citations Bertrand Coiffier, Anton Hagenbeek et al. Journal of Clinical Oncology profile →
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

1999 2.8k citations Anton Hagenbeek, Wolfgang Hiddemann et al. Journal of Clinical Oncology profile →
Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma

1995 1.8k citations Anton Hagenbeek, Dominique Bron et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anton Hagenbeek Netherlands	48	11.4k	7.7k	4.3k	3.1k	2.8k	263	16.4k
Christian Gisselbrecht France	61	15.1k 1.3×	11.6k 1.5×	5.4k 1.3×	4.1k 1.3×	1.7k 0.6×	285	20.1k
Andrew D. Zelenetz United States	65	13.8k 1.2×	8.6k 1.1×	6.0k 1.4×	3.6k 1.2×	1.6k 0.6×	376	19.3k
Hervé Tilly France	72	17.1k 1.5×	11.5k 1.5×	6.8k 1.6×	4.7k 1.5×	2.2k 0.8×	416	22.5k
Corinne Haïoun France	70	14.0k 1.2×	8.4k 1.1×	4.6k 1.1×	3.5k 1.1×	1.1k 0.4×	400	17.7k
Josette Brière France	53	10.0k 0.9×	7.4k 1.0×	3.3k 0.8×	2.8k 0.9×	840 0.3×	190	13.6k
Pier Luigi Zinzani Italy	71	16.3k 1.4×	10.7k 1.4×	5.6k 1.3×	4.0k 1.3×	1.4k 0.5×	924	22.0k
Emanuele Zucca Switzerland	66	16.0k 1.4×	8.3k 1.1×	5.1k 1.2×	5.9k 1.9×	1.4k 0.5×	404	21.0k
Michael Pfreundschuh Germany	70	10.1k 0.9×	8.3k 1.1×	4.1k 1.0×	3.3k 1.1×	1.4k 0.5×	421	20.6k
Philippe Gaulard France	77	16.9k 1.5×	11.6k 1.5×	5.0k 1.2×	3.7k 1.2×	1.2k 0.4×	383	23.0k
Norbert Schmitz Germany	69	10.1k 0.9×	8.3k 1.1×	4.7k 1.1×	3.2k 1.0×	5.8k 2.0×	397	17.1k

Countries citing papers authored by Anton Hagenbeek

Since Specialization

Citations

This map shows the geographic impact of Anton Hagenbeek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Hagenbeek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Hagenbeek more than expected).

Fields of papers citing papers by Anton Hagenbeek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Hagenbeek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Hagenbeek. The network helps show where Anton Hagenbeek may publish in the future.

Co-authorship network of co-authors of Anton Hagenbeek

This figure shows the co-authorship network connecting the top 25 collaborators of Anton Hagenbeek. A scholar is included among the top collaborators of Anton Hagenbeek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton Hagenbeek. Anton Hagenbeek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Casulo, Carla, Jesse G. Dixon, Fang‐Shu Ou, et al.. (2021). Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials. Blood Advances. 5(6). 1737–1745. 3 indexed citations

Kersten, Marie José, Josée M. Zijlstra, Wouter J. Plattel, et al.. (2020). Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study. Haematologica. 106(4). 1129–1137. 60 indexed citations

Struemper, Herbert, Mark Sale, Bela Patel, et al.. (2014). Population pharmacokinetics of ofatumumab in patients with chronic lymphocytic leukemia, follicular lymphoma, and rheumatoid arthritis. The Journal of Clinical Pharmacology. 54(7). 818–827. 22 indexed citations

Meerten, Tom van & Anton Hagenbeek. (2011). Novel antibodies against follicular non-Hodgkin’s lymphoma. Best Practice & Research Clinical Haematology. 24(2). 231–256. 13 indexed citations

Oers, Marinus H. J. van, Evelyn Tönnissen, M. van Glabbeke, et al.. (2010). BCL-2/IgH Polymerase Chain Reaction Status at the End of Induction Treatment Is Not Predictive for Progression-Free Survival in Relapsed/Resistant Follicular Lymphoma: Results of a Prospective Randomized EORTC 20981 Phase III Intergroup Study. Journal of Clinical Oncology. 28(13). 2246–2252. 34 indexed citations

Hagenbeek, Anton, Luis Fayad, Vincent Delwail, et al.. (2009). Evaluation of Ofatumumab, a Novel Human CD20 Monoclonal Antibody, as Single Agent Therapy in Rituximab-Refractory Follicular Lymphoma.. Blood. 114(22). 935–935. 32 indexed citations

Vitolo, Umberto, Franck Morschhauser, John Radford, et al.. (2008). CONSOLIDATION OF FIRST REMISSION WITH 90Y-IBRITUMOMAB TIUXETAN IN ADVANCED FOLLICULAR NON-HODGKIN'S LYMPHOMA (FL): RESULTS FROM THE PHASE 3 RANDOMIZED FIRST-LINE INDOLENT TRIAL (FIT). Annals of Oncology. 19. 231–232. 1 indexed citations

Morschhauser, Franck, John Radford, Achiel Van Hoof, et al.. (2008). Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma. Journal of Clinical Oncology. 26(32). 5156–5164. 314 indexed citations

Veer, Mars B. vanʼt, Daphne de Jong, Marius MacKenzie, et al.. (2008). High‐dose Ara‐C and beam with autograft rescue in R‐CHOP responsive mantle cell lymphoma patients. British Journal of Haematology. 144(4). 524–530. 47 indexed citations

10.

Noordijk, Evert M., Patrice Carde, N. Dupouy, et al.. (2006). Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials. Journal of Clinical Oncology. 24(19). 3128–3135. 149 indexed citations

11.

Hagenbeek, Anton, et al.. (2005). A novel fully human anti-CD20 monoclonal antibody: First clinical results from an ongoing phase I/II trial in patients with follicular non-Hodgkin's lymphoma. Annals of Oncology. 16. 71–71. 3 indexed citations

12.

Rozemuller, Henk, et al.. (2004). Enhanced engraftment of human cells in RAG2/γc double-knockout mice after treatment with CL2MDP liposomes. Experimental Hematology. 32(11). 1118–1125. 29 indexed citations

13.

Aleman, Berthe M.P., M. Henry‐Amar, Umberto Tirelli, et al.. (2001). Involved field irradiation (IFRT) does not improve outcome in patients with stage III/IV Hodgkin's lymphoma (HL) in complete remission after MOPP/ABV (M/A): Results of the randomised EORTC trial 20884. Blood. 98(11). 6 indexed citations

14.

Leeuwen, Flora E. van, Willem J. Klokman, Mars B. vanʼt Veer, et al.. (2000). Long-Term Risk of Second Malignancy in Survivors of Hodgkin’s Disease Treated During Adolescence or Young Adulthood. Journal of Clinical Oncology. 18(3). 487–487. 302 indexed citations

15.

Teodorović, Ivana, Stefania Pittaluga, Hanneke C. Kluin‐Nelemans, et al.. (1995). Efficacy of four different regimens in 64 mantle-cell lymphoma cases. Journal of Clinical Oncology. 13(11). 4 indexed citations

16.

Arkesteijn, Ger J. A., et al.. (1995). Chromosome specific DNA hybridization in suspension for flow cytometric detection of chimerism in bone marrow transplantation and leukemia. Cytometry. 19(4). 353–360. 14 indexed citations

17.

Carde, Patrice, Anton Hagenbeek, M. Hayat, et al.. (1993). Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.. Journal of Clinical Oncology. 11(11). 2258–2272. 139 indexed citations

18.

Tirelli, Umberto, Vittorina Zagonel, Diego Serraino, et al.. (1988). Non Hodgkin's Lymphomas in 137 patients aged 70 years or older: a retrospective EORTC Lymphoma Group Study. Journal of Clinical Oncology. 11. 1708–1713. 4 indexed citations

19.

Hagenbeek, Anton & Anton C. Martens. (1981). The effect of fractionated versus unfractionated total body irradiation on the growth of the bn acute myelocytic leukemia. International Journal of Radiation Oncology*Biology*Physics. 7(8). 1075–1079. 20 indexed citations

20.

Bekkum, D. W. van & Anton Hagenbeek. (1977). Relevance of the BN leukemia as a model for human acute myeloid leukemia. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact